Cambridge Investment Research Advisors
ASXC

Cambridge Investment Research Advisors’s Asensus Surgical, Inc. ASXC Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,075
Closed -$3K – 3413
2023
Q4 		$3K Sell
10,075
-10,000
-50% -$2.58K ﹤0.01% 3179
2023
Q3 		$5K Buy
20,075
+4,843
+32% +$1.76K ﹤0.01% 3125
2023
Q2 		$8K Hold
15,232
– – ﹤0.01% 3156
2023
Q1 		$10K Buy
+15,232
New +$10.3K ﹤0.01% 3134
2022
Q4 		– Sell
-20,971
Closed -$9K – 3232
2022
Q3 		$9K Hold
20,971
– – ﹤0.01% 3026
2022
Q2 		$8K Hold
20,971
– – ﹤0.01% 3025
2022
Q1 		$13K Sell
20,971
-5,000
-19% -$3.85K ﹤0.01% 3135
2021
Q4 		$29K Sell
25,971
-13,600
-34% -$21K ﹤0.01% 3125
2021
Q3 		$73K Sell
39,571
-6,000
-13% -$13.5K ﹤0.01% 2996
2021
Q2 		$144K Buy
45,571
+13,507
+42% +$33.8K ﹤0.01% 2906
2021
Q1 		$104K Buy
+32,064
New +$116K ﹤0.01% 2753
2019
Q4 		– Sell
-2,742
Closed -$22K – 2484
2019
Q3 		$22K Sell
2,742
-10
-0.4% -$136 ﹤0.01% 2318
2019
Q2 		$49K Sell
2,752
-3,696
-57% -$80.9K ﹤0.01% 2147
2019
Q1 		$200K Buy
6,448
+4,169
+183% +$140K ﹤0.01% 2077
2018
Q4 		$67K Buy
2,279
+173
+8% +$7.86K ﹤0.01% 2067
2018
Q3 		$159K Buy
2,106
+919
+77% +$62.2K ﹤0.01% 2104
2018
Q2 		$67K Buy
+1,187
New +$43.2K ﹤0.01% 2140
2018
Q1 		– Sell
-771
Closed -$19K – 2243
2017
Q4 		$19K Sell
771
-364
-32% -$11.2K ﹤0.01% 2096
2017
Q3 		$21K Hold
1,135
– – ﹤0.01% 1981
2017
Q2 		$10K Hold
1,135
– – ﹤0.01% 1923
2017
Q1 		$18K Sell
1,135
-396
-26% -$6.86K ﹤0.01% 1759
2016
Q4 		$26K Buy
1,531
+539
+54% +$11K ﹤0.01% 1645
2016
Q3 		$22K Buy
+992
New +$18.1K ﹤0.01% 1723

Other funds holding ASXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

Cambridge Investment Research Advisors's ASXC Position: Q1 2024 in Review

Cambridge Investment Research Advisors sold out of Asensus Surgical, Inc. (ASXC) in Q1 2024, closing a stake of 10,075 shares — an estimated $3K sold.

Cambridge Investment Research Advisors first reported a position in ASXC in Q3 2016 and held it in 23 quarters. The position peaked at $200K in Q1 2019. 72 funds tracked by Wall St. Rank hold ASXC as of Q1 2024.

  • Cambridge Investment Research Advisors reported no remaining Asensus Surgical, Inc. position as of Q1 2024 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 10,075 Asensus Surgical, Inc. shares in Q1 2024, an estimated $3K.
  • Cambridge Investment Research Advisors first reported a position in Asensus Surgical, Inc. in Q3 2016 and held it in 23 quarters.
  • Cambridge Investment Research Advisors's Asensus Surgical, Inc. position peaked at $200K in Q1 2019.
  • 72 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q1 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.